BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1950440)

  • 1. Ofloxacin for the treatment of leprosy.
    Ji B; Grosset J
    Acta Leprol; 1991; 7(4):321-6. PubMed ID: 1950440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
    Grosset JH; Ji BH; Guelpa-Lauras CC; Perani EG; N'Deli LN
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial of pefloxacin and ofloxacin in lepromatous leprosy.
    Fajardo TT; Villahermosa LG; Cruz EC; Cellona RV; Balagon MV; Abalos RM; Gelber RH
    Lepr Rev; 2004 Dec; 75(4):389-97. PubMed ID: 15685736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of pefloxacin in the treatment of lepromatous leprosy.
    N'Deli L; Guelpa-Lauras CC; Perani EG; Grosset JH
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):12-8. PubMed ID: 2181041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ofloxacin against Mycobacterium leprae in the mouse.
    Grosset JH; Guelpa-Lauras CC; Perani EG; Beoletto C
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):259-64. PubMed ID: 3045223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ofloxacin containing combined drug regimens in the treatment of multibacillary leprosy.
    Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):803-10. PubMed ID: 9656405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
    Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
    J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.
    Guelpa-Lauras CC; Perani EG; Giroir AM; Grosset JH
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):70-7. PubMed ID: 3549940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.
    Cunha Mda G; Virmond M; Schettini AP; Cruz RC; Ura S; Ghuidella C; Viana Fdos R; Avelleira JC; Campos AA; Filho B
    Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice.
    Franzblau SG; Parrilla ML; Chan GP
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):66-9. PubMed ID: 8392100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.
    Pattyn SR
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):613-7. PubMed ID: 1666402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
    Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
    Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrabacterial sodium-to-potassium ratios and ATP contents of Mycobacterium leprae from ofloxacin-treated patients.
    Dietz M; Haas M; Lindner B; Dhople AM; Tebebe YB; Seydel U
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):548-57. PubMed ID: 1802937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
    Dhople AM; Ibanez MA
    Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activity of rifabutin against Mycobacterium leprae.
    Yoder LJ; Jacobson RR; Hastings RC
    Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice.
    Burgos J; de la Cruz E; Paredes R; Andaya CR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):253-8. PubMed ID: 22125933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
    Ji B; Perani EG; Petinon C; Grosset JH
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):556-61. PubMed ID: 1338596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1996 Dec; 67(4):260-79. PubMed ID: 9033197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pefloxacin in leprosy.
    Bharti R
    Indian J Lepr; 1994; 66(4):443-8. PubMed ID: 7714353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.